Table 1 Descriptive statistics of the study population.
CKD stage | n (male/female) | Age (years) | Height (m) | Weight (kg) | BMI (kg/m2) | Systolic blood pressure (mmHg) | Diastolic blood pressure (mmHg) | Serum sodium concentration (mmol/L) | Hematocrit (%) | Albumin/Creatinine ratio in urine |
|---|---|---|---|---|---|---|---|---|---|---|
Control | 6 (3/3) | 45 ± 14.75 | 1.80 ± 0.06 | 83.3 ± 6.1 | 25.8 ± 3.5 | 126 ± 8 | 83 ± 4 | n/a | n/a | n/a |
I | 9 (5/4) | 44 ± 15.39 | 1.75 ± 0.09 | 77.3 ± 21.0 | 26.0 ± 6.0 | 143 ± 9 | 97 ± 6 | 141.3 ± 0.6 | 39.1 ± 9.1 | 204 [126–282] |
II | 4 (2/2) | 42 ± 12.84 | 1.76 ± 0.06 | 80.5 ± 8.7 | 26.0 ± 3.4 | 128 ± 21 | 84 ± 12 | 138.4 ± 5.9 | 40.1 ± 4.0 | 19.5 [6–1565] |
IIIa | 7 (4/3) | 54 ± 9.72 | 1.76 ± 0.06 | 85.6 ± 17.5 | 27.4 ± 4.8 | 133 ± 14 | 87 ± 8 | 140.9 ± 2.5 | 40.9 ± 4.4 | 45 [17–166.5] |
IIIb | 8 (4/4) | 56.75 ± 13.56 | 1.74 ± 0.13 | 75.6 ± 15.9 | 24.5 ± 2.5 | 140 ± 20 | 84 ± 12 | 142.3 ± 1.9 | 37.88 ± 4.4 | 56 [15–47] |
IV | 5 (2/3) | 49.44 ± 12.65 | 1.71 ± 0.12 | 74.8 ± 17.2 | 25.5 ± 4.9 | 131 ± 18 | 87 ± 9 | 140.4 ± 2.0 | 33.68 ± 5.2 | 173.5 [72.5–1343] |
V | 16 (8/8) | 57.4 ± 15.55 | 1.74 ± 0.11 | 93.6 ± 27.2 | 30.8 ± 9.5 | 135 ± 4 | 88 ± 7 | 144.8 ± 3.3 | 35.2 ± 4.0 | 3099 [362.3–5036] |
ESKD/HD | 9 (5/4) | 67.62 ± 14.02 | 1.67 ± 0.11 | 71.6 ± 13.3 | 25.5 ± 5.1 | 132 ± 16 | 70 ± 9 | 138.8 ± 3.3 | 32.04 ± 3.0 | 13,516* |
Total | 64 (33/31) | 54.69 ± 15.04 | 1.74 ± 0.11 | 78.9 ± 16.4 | 26.1 ± 4.9 | 133 ± 16 | 83 ± 11 | 140.8 ± 3.3 | 36.5 ± 5.5 | 90 [21.5–845] |
